A Clinical Trial to study the efficacy & safety of Colebrookea Oppositifolia (Aceteoside) in acute hepatitis patients.
- Registration Number
- CTRI/2008/091/000090
- Lead Sponsor
- Council of Scientific & Industrial Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
1.Individuals between 18-60 years of age of either sex suffering from acute hepatitis A/B. Diagnosis will be made on the basis of clinical history or immunological markers.
2.Patients ready to abide by trial procedures and to give informed consent.
1.Patients over 60 years or less than 16 years of age.
2.Pregnant or lactating mothers / complicated with Non A & B Hepatitis or Drug / alcoholic hepatitis / chronic active hepatitis.
3.Suspicion of auto â?? immune disease concomitant presence of disease of Cardiovascular System, renal or haemopoietic System or mental disease.
4.Patients using drugs which are likely to affect liver function tests e.g. NSAIDâ??s, Anticonvulsants, anti-diabeitic, statins , hormones, erythromycin etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measures will be improvement in liver function tests, immunological test and liver ultrasound imaging as compared to base line using appropriate statistical test.Timepoint: 6 weeks onwards
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable